Natus Medical (BABY) Tops Q3 EPS by 5c; Guides Above the Street

Natus Medical (NASDAQ: BABY) reported Q3 EPS of $0.39, $0.05 better than the analyst estimate of $0.34. Revenue for the quarter came in at $90.9 million versus the consensus estimate of $89.94 million.

GUIDANCE:

Natus Medical sees Q4 2016 EPS of $0.52-$0.55, versus the consensus of $0.48. Natus Medical sees Q4 2016 revenue of $107-109 million, versus the consensus of $104.6 million.

Natus Medical sees FY2016 EPS of $1.63-$1.66, versus the consensus of $1.55. Natus Medical sees FY2016 revenue of $381.2-383.2 million, versus the consensus of $377.83 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• L3Harris CEO steps down amid conduct review, shares drop
• InspireMD (NSPR) Tops Q2 EPS by 1c